[The effect of matrine on the signal transduction pathway of transforming growth factor-beta1 in human lung fibroblast cells].
Wei Ling, Min Xie, Junqing Shi
Abstract
Wei Ling, Min Xie, Junqing Shi
Abstract
OBJECTIVE: To investigate the effect of matrine on the signal transduction pathway of transforming growth factor-beta1 (TGF-beta1). METHODS: The effect of TGF-beta1, Staurosporine, PD98059 and matrine on the expression of CTGF, CTGF mRNA, p-Smad2, and p-ERK1/2 were evaluated by Western blot in cultured HLF-02 cells. Immunohistochemical staining was applied to test the expression of CTGF and the expression level of CTGF mRNA was assayed by RT-PCR. RESULTS: Basal levels of CTGF protein were observed in cultured HLF-02. The expression of CTGF, CTGF mRNA, p-Smad2 and p-ERK1/2, in HLF-02 cells were stimulated significantly (P < 0.01) by 1 ng/mL TGF-beta1 treatment. The increase of CTGF protein was inhibited significantly by pre-incubation with Staurosporine (SP) and PD98059 (P < 0.01). And matrine could markedly inhibited the up-regulation of CTGF, CTGF mRNA, p-Smad2 and p-ERK1/2 (P < 0.05 or P < 0.01) in a concentration-dependant manner. CONCLUSION: CTGF, CTGF mRNA, p-Smad2 and p-ERK1/2 of HLF-02 cells could be significantly up-regulated after treated with TGF-beta1, and these increases could be inhibited significantly by matrine. This implied that matrine inhibit the expression of CTGF and CTGF mRNA induced by TGF-beta1 through the Smad2 and ERK signal transduction pathways.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the effect of matrine on the signal transduction pathway of transforming growth factor-beta1 (TGF-beta1). METHODS: The effect of TGF-beta1, Staurosporine, PD98059 and matrine on the expression of CTGF, CTGF mRNA, p-Smad2, and p-ERK1/2 were evaluated by Western blot in cultured HLF-02 cells. Immunohistochemical staining was applied to test the expression of CTGF and the expression level of CTGF mRNA was assayed by RT-PCR. RESULTS: Basal levels of CTGF protein were observed in cultured HLF-02. The expression of CTGF, CTGF mRNA, p-Smad2 and p-ERK1/2, in HLF-02 cells were stimulated significantly (P < 0.01) by 1 ng/mL TGF-beta1 treatment. The increase of CTGF protein was inhibited significantly by pre-incubation with Staurosporine (SP) and PD98059 (P < 0.01). And matrine could markedly inhibited the up-regulation of CTGF, CTGF mRNA, p-Smad2 and p-ERK1/2 (P < 0.05 or P < 0.01) in a concentration-dependant manner. CONCLUSION: CTGF, CTGF mRNA, p-Smad2 and p-ERK1/2 of HLF-02 cells could be significantly up-regulated after treated with TGF-beta1, and these increases could be inhibited significantly by matrine. This implied that matrine inhibit the expression of CTGF and CTGF mRNA induced by TGF-beta1 through the Smad2 and ERK signal transduction pathways.
Key concepts: CTGF, Growth factor, Signal transduction, Staurosporine, MAPK/ERK pathway, Messenger RNA, Western blot, Molecular biology